Technology for Older People Doesn’t Have to Be Ugly

‘Big, beige and boring’ is out. A new emphasis on aesthetics is in, and it could transform elder tech.

Technologies aimed at keeping older people healthy have long combined cumbersome form and infantilizing function. Way back in 1947, you could strap on a wearable heart-rate detector and go for a stroll. (At 85 pounds, it was “wearable” only on your back, and not for long.) In 1975 the American International Telephone Corp. began selling necklace-style alert systems that could summon an ambulance in an emergency. By 2009 you could buy a wearable device to detect if you’d taken a fall in your home.

Only today is the elder-tech industry finally going mainstream. In September, Apple announced its latest Watch, which includes all the aforementioned capabilities in a small, sleek package. This is merely the latest in a series of developments suggesting a tipping point: Health technology for older people is now designed not merely to be endured, but embraced.

Historically, many such technologies prioritized bodily needs over aesthetics. This is true of the Life Alert necklace of yore and some fall-detection startups today. Many of these technologies were designed by young people who couldn’t imagine themselves actually using them. The byword for the boatloads of medication-reminder systems, simplified cellphones, hearing aids, gigantic remote controls and so forth became “BBB”: big, beige and boring.

This forced older consumers to choose: Spend money and energy on an unappealing technology, or go without it. Many picked the latter, with real health consequences. According to the Hearing Loss Association of America, people with hearing loss go seven years on average between detecting a problem and seeking a hearing device. That hesitation can lead to social isolation and household accidents. Perhaps 4% of Americans who could benefit from a personal emergency-response system such as Life Alert have one, and even those who own the devices tend not to wear them, or fail to use them when emergency strikes.

Which companies, we wondered, would go all-in and develop new products serving older adults’ desires and aspirations? Which would commit to user experience like tech companies do for other consumers? The market exists to justify it; the aging of the baby boom generation and lower fertility rates mean that by 2030 the percentage of the U.S. population 65 and older will be as high as it is in Florida today.

An early sign of life came in 2014. The online pharmacy PillPack announced it would package medications not according to type, but time of day to be consumed. The meds came in ticker-tape dispensers that made it hard to forget if you’d already taken your pills. Such packaging, PillPack founder T.J. Parker told us, had been a fixture of nursing homes since the late 1980s, but making it into a consumer product was an innovation.

Amazon bought PillPack this year for $1 billion. Two months later, Best Buy announced it is purchasing GreatCall, the maker of the elder-oriented Jitterbug phone, for $800 million. Now with Apple’s entry into the personal emergency-response market, 2018 will go down as the year elder tech sneaked into the wider marketplace. Tucked away within the elegant Apple Watch, technologies like fall detection and heart-rate monitors may be cured of their stigmas.

As product design shifts to the major tech companies, we may soon see heightened attention to detail, usability and engineering. Aesthetics, heretofore largely ignored in the elder-tech industry, will likely become central. And as the focus on older consumers’ preferences goes beyond the development of better products to the creation of new product categories, the experience of later life may improve substantially. That’s the promise of the longevity economy: A longer life can—and should—be a better life.

Mr. Coughlin is founder and director of the Massachusetts Institute of Technology AgeLab and author of “The Longevity Economy: Inside the World’s Fastest-Growing, Most Misunderstood Market.” Mr. Yoquinto is a science writer and research associate at the MIT AgeLab.

Source: Wall Street Journal

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Joe Biden’s ‘Cancer Moonshot’ May be Derailed by New Policies, Including His Own

For almost a decade, President Biden has championed a bold “cancer moonshot” — an initiative he first launched in 2016, revived early in his administration, and reiterated during this year’s State of the Union. It is a laudable goal, especially for an aging nation where cancer and chronic disease are on the rise. There’s just one problem: Recent federal and state policies are poised to derail the incredible progress made in oncology since 2016. A rash of policies now threatens to limit access and slow progress towards new breakthroughs.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

Kishida and Biden Face a Similar Demographic Crisis

Your front page story “Japan wrestles with age-old problem as population declines at record rate” (Report, April 13) and the letter in the same edition from Tim Hill, “A gently declining population is no reason to panic”, both describe what all societies face as they modernise in the 21st century.

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.

New Report From the Global Coalition on Aging Highlights the Connection Between Adult Immunization and Economic Health in Aging APEC Region

As leaders from across the Asia-Pacific Economic Cooperation (APEC) region convene in San Francisco over the next week, a new report from the Global Coalition on Aging (GCOA) points to investments in healthy aging as a growing economic imperative amid the region’s changing demographics. According to the new report, programs that keep populations healthy, active, and productive – like adult immunization – are increasingly becoming a prerequisite for economic stability and growth.